NDA 50639, held by Pfizer. Clindamycin Phosphate.
As of Nov 15, 2026, NDA 50639 (Cleocin Phosphate In Dextrose 5% In Plastic Container), held by Pfizer, was first approved by FDA on Aug 30, 1989, with 35 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 30, 1989 | Original applicationNew dosage form · Standard review | Approved | None posted |
| Cleocin Phosphate In Dextrose 5% In Plastic ContainerEQ 6MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · injectable;injection | Clindamycin Phosphate | DiscontinuedReference drug |
| Cleocin Phosphate In Dextrose 5% In Plastic ContainerEQ 12MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · injectable;injection | Clindamycin Phosphate | DiscontinuedReference drug |
| Cleocin Phosphate In Dextrose 5% In Plastic ContainerEQ 18MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · injectable;injection | Clindamycin Phosphate | DiscontinuedReference drug |
| Mar 26, 2026 | Supplement 45Labeling · Standard review | Approved | |
| Feb 12, 2026 | Supplement 44Labeling · Standard review | Approved | |
| May 20, 2022 | Supplement 42Labeling · Standard review | Approved | |
| Dec 4, 2021 | Supplement 43Labeling · Standard review | Approved | |
| Mar 4, 2020 | Supplement 41Labeling · Standard review | Approved | |
| Jun 19, 2019 | Supplement 40Labeling · Standard review | Approved | |
| Apr 16, 2018 | Supplement 38Labeling · Standard review | Approved | |
| May 2, 2017 | Supplement 35Labeling · Standard review | Approved | |
| May 2, 2017 | Supplement 37Labeling · Standard review | Approved | |
| Aug 5, 2016 | Supplement 33Labeling · Standard review | Approved | |
| Aug 5, 2016 | Supplement 34Labeling · Standard review | Approved | |
| May 20, 2016 | Supplement 32Manufacturing · Standard review | Approved | None posted |
| Mar 24, 2016 | Supplement 31Labeling · Standard review | Approved | |
| Sep 18, 2014 | Supplement 30Manufacturing · Standard review | Approved | None posted |
| Jun 25, 2014 | Supplement 29Labeling · Standard review | Approved | |
| Jun 25, 2014 | Supplement 28Labeling · Standard review | Approved | |
| Jun 25, 2014 | Supplement 27Labeling · Standard review | Approved | |
| Oct 9, 2013 | Supplement 26Manufacturing · Standard review | Approved | None posted |
| Jun 26, 2013 | Supplement 25Manufacturing · Standard review | Approved | None posted |
| Jun 7, 2011 | Supplement 22Labeling | Approved | |
| Apr 14, 2008 | Supplement 16Labeling · Standard review | Approved | |
| Feb 21, 2008 | Supplement 15Labeling · Standard review | Approved | |
| Sep 29, 2004 | Supplement 13Labeling · Standard review | Approved | |
| Jan 28, 2004 | Supplement 14Labeling · Standard review | Approved | |
| Mar 9, 1998 | Supplement 10Manufacturing · Standard review | Approved | None posted |
| Dec 12, 1997 | Supplement 12Labeling · Standard review | Approved | None posted |
| Jul 17, 1997 | Supplement 11Labeling · Standard review | Approved | None posted |
| Mar 17, 1997 | Supplement 5Labeling | Approved | None posted |
| Dec 20, 1995 | Supplement 7Labeling · Standard review | Approved | None posted |
| Feb 21, 1995 | Supplement 9Labeling · Standard review | Approved | None posted |
| Apr 5, 1993 | Supplement 8Manufacturing · Standard review | Approved | None posted |
| May 21, 1992 | Supplement 4Manufacturing · Standard review | Approved | None posted |
| Jun 11, 1991 | Supplement 2Labeling | Approved | None posted |
| Apr 18, 1991 | Supplement 1Manufacturing · Standard review | Approved | None posted |
| Apr 10, 1991 | Supplement 3Manufacturing · Standard review | Approved | None posted |
| Aug 30, 1989 | Original applicationNew dosage form · Standard review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters